uracil has been researched along with Cirrhosis in 9 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we explored whether alogliptin, a dipeptidyl peptidase-4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model." | 7.85 | Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. ( Jiang, N; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Tse, G; Wang, X; Yang, Y; Zhang, X; Zhang, Z; Zhao, Y, 2017) |
| " Alogliptin alleviated ventricular hypertrophy, interstitial fibrosis and diastolic dysfunction in diabetic rabbits." | 3.88 | Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits. ( Jiang, N; Li, G; Liu, C; Liu, R; Liu, T; Qiu, J; Suo, Y; Tse, G; Yang, Y; Zhang, X; Zhang, Z; Zhao, Y, 2018) |
| " In this study, we explored whether alogliptin, a dipeptidyl peptidase-4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model." | 3.85 | Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. ( Jiang, N; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Tse, G; Wang, X; Yang, Y; Zhang, X; Zhang, Z; Zhao, Y, 2017) |
| "We investigated the effects of a DPP-4 inhibitor, alogliptin, on atrial fibrillation (AF) in a rabbit model of heart failure caused by ventricular tachypacing (VTP)." | 3.81 | Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits. ( Hirai, M; Inden, Y; Murohara, T; Shimano, M; Takefuji, M; Tsuji, Y; Yamamoto, T; Yanagisawa, S; Yoshida, N, 2015) |
| " Dose-response curves following single intraperitoneal injections of purified CYN (at 0, 16, 32, 64 and 128 μg CYN/kg body weight) were created in 10-week-old male BALB/C mice (n = 4)." | 1.48 | Renal tubular damage caused by cylindrospermopsin (cyanotoxin) in mice. ( Magalhães, VF; Moraes, ACN, 2018) |
| " Here we demonstrate that early, chronic administration of MYK-461 suppresses the development of ventricular hypertrophy, cardiomyocyte disarray, and myocardial fibrosis and attenuates hypertrophic and profibrotic gene expression in mice harboring heterozygous human mutations in the myosin heavy chain." | 1.43 | A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. ( Anderson, RL; Evanchik, MJ; Gorham, JM; Green, EM; Harrison, BC; Henze, M; Kawas, R; Leinwand, LA; McDowell, RS; Oslob, JD; Rodriguez, HM; Seidman, CE; Seidman, JG; Song, Y; Spudich, JA; Wakimoto, H; Wan, W, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Alsemeh, AE | 1 |
| Abdullah, DM | 1 |
| Zhang, X | 2 |
| Zhang, Z | 2 |
| Zhao, Y | 2 |
| Jiang, N | 2 |
| Qiu, J | 2 |
| Yang, Y | 2 |
| Li, J | 1 |
| Liang, X | 1 |
| Wang, X | 1 |
| Tse, G | 2 |
| Li, G | 2 |
| Liu, T | 2 |
| Moraes, ACN | 1 |
| Magalhães, VF | 1 |
| Suo, Y | 1 |
| Liu, R | 1 |
| Liu, C | 1 |
| Yamamoto, T | 1 |
| Shimano, M | 1 |
| Inden, Y | 1 |
| Takefuji, M | 1 |
| Yanagisawa, S | 1 |
| Yoshida, N | 1 |
| Tsuji, Y | 1 |
| Hirai, M | 1 |
| Murohara, T | 1 |
| Beinhardt, S | 1 |
| Peck-Radosavljevic, M | 1 |
| Hofer, H | 1 |
| Ferenci, P | 1 |
| Green, EM | 1 |
| Wakimoto, H | 1 |
| Anderson, RL | 1 |
| Evanchik, MJ | 1 |
| Gorham, JM | 1 |
| Harrison, BC | 1 |
| Henze, M | 1 |
| Kawas, R | 1 |
| Oslob, JD | 1 |
| Rodriguez, HM | 1 |
| Song, Y | 1 |
| Wan, W | 1 |
| Leinwand, LA | 1 |
| Spudich, JA | 1 |
| McDowell, RS | 1 |
| Seidman, JG | 1 |
| Seidman, CE | 1 |
| Saab, S | 1 |
| Parisé, H | 1 |
| Virabhak, S | 1 |
| Wang, A | 1 |
| Marx, SE | 1 |
| Sanchez Gonzalez, Y | 1 |
| Misurski, D | 1 |
| Johnson, S | 1 |
| Uchida, T | 1 |
| Oda, T | 1 |
| Matsubara, H | 1 |
| Watanabe, A | 1 |
| Takechi, H | 1 |
| Oshima, N | 1 |
| Sakurai, Y | 1 |
| Kumagai, H | 1 |
1 review available for uracil and Cirrhosis
| Article | Year |
|---|---|
Interferon-free antiviral treatment of chronic hepatitis C in the transplant setting.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cholestasis, Intrahepatic; Clinical Trials | 2015 |
8 other studies available for uracil and Cirrhosis
| Article | Year |
|---|---|
Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades.
Topics: Animals; Antioxidants; Cyclophosphamide; Fibrosis; Lung; Nerve Tissue Proteins; Oxidative Stress; Ph | 2022 |
Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Experimental; Dipeptidyl-Peptida | 2017 |
Renal tubular damage caused by cylindrospermopsin (cyanotoxin) in mice.
Topics: Alkaloids; Animals; Bacterial Toxins; Biomarkers; Collagen; Cyanobacteria Toxins; Dose-Response Rela | 2018 |
Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Dipeptidyl-Peptidase | 2018 |
Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits.
Topics: Animals; Atrial Fibrillation; Blotting, Western; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; E | 2015 |
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.
Topics: Adenosine Triphosphatases; Animals; Benzylamines; Cardiac Myosins; Cardiomyopathy, Hypertrophic, Fam | 2016 |
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.
Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbama | 2016 |
Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Urea Nitrogen; Calci | 2017 |